SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ionis Pharmaceuticals (IONS)
IONS 80.29-1.8%Jan 23 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: marc ultra who wrote (1984)5/11/1998 11:06:00 AM
From: David Bogdanoff  Read Replies (1) of 4676
 
TO all;

ISIS was favorably mentioned by Jim McCants of the Med. Tech. newsletter on CNBC this morning. He said that a couple of products were near approval and 20 were in p.II. Further, he said that the use of antisense in conjunction with chemotherapy would greatly increase its acceptance by oncologists. He included Isis among several stocks with good management and whose technology was not built into the stock price. Overall, very favorable publicity.

David
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News